Amgen discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses for the treatment of illness in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine. The company was founded in 1980 and is based in Thousand Oaks, California.
AMGN Price Forecast Based on DCF Valuation
DCF Fair Value Target:
Below please find a table outlining a discounted cash flow forecast for AMGN, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Amgen Inc ranked in the 43th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 13.67%. As for the metrics that stood out in our discounted cash flow analysis of Amgen Inc, consider:
As a business, AMGN is generating more cash flow than 95% of positive cash flow stocks in the Healthcare.
Amgen Inc's weighted average cost of capital (WACC) is 8%; for context, that number is higher than just 18.87% of tickers in our DCF set.
AMGN's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than just 18.87% of tickers in our DCF set.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
Want more companies with a valuation profile/forecast similar to that of Amgen Inc? See IART, DXCM, FONR, PRAH, and RSCF.
DUBLIN--(BUSINESS WIRE)--The "Gene Delivery Systems - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Gene Delivery Systems Market to Reach $4 Billion by 2027 Amid the COVID-19 crisis, the global market for Gene Delivery Systems estimated at US$2.6 Billion in the year 2020, is projected to reach a revised size of US$4 Billion by 2027, growing at a CAGR of 6.4% over the period 2020-2027. Viral Gene Delivery, one of the segments analyze
Rheumatoid Arthritis Drugs Market The Global Rheumatoid Arthritis Drugs Market report gives a comprehensive overview of the Rheumatoid Arthritis Drugs market scenario to present accurate forecasts of the upcoming years with special focus on the competitive landscape, market segmentation, current
The market report study titled ‘Global Psoriasis Drugs Market Report’ published by Reports and Data offers in-depth and comprehensive research describing the scope of the market and market insights until 2027. The report will include details about potential opportunities, new